SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $41,000 | -66.4% | 3,697 | -94.4% | 0.00% | -100.0% |
| Q1 2020 | $122,000 | +577.8% | 66,327 | +1175.0% | 0.00% | – |
| Q4 2019 | $18,000 | -79.5% | 5,202 | -87.4% | 0.00% | -100.0% |
| Q3 2019 | $88,000 | -57.3% | 41,178 | -46.7% | 0.00% | -50.0% |
| Q2 2019 | $206,000 | +186.1% | 77,322 | +159.3% | 0.00% | +100.0% |
| Q4 2018 | $72,000 | -81.6% | 29,818 | -66.4% | 0.00% | -66.7% |
| Q3 2018 | $391,000 | +10.1% | 88,860 | +80.0% | 0.00% | 0.0% |
| Q2 2018 | $355,000 | +1513.6% | 49,353 | +348.6% | 0.00% | – |
| Q2 2017 | $22,000 | -35.3% | 11,001 | +27.3% | 0.00% | – |
| Q1 2017 | $34,000 | -19.0% | 8,645 | 0.0% | 0.00% | – |
| Q4 2016 | $42,000 | +10.5% | 8,645 | +21.2% | 0.00% | -100.0% |
| Q1 2016 | $38,000 | +245.5% | 7,135 | +468.5% | 0.00% | – |
| Q3 2015 | $11,000 | -21.4% | 1,255 | +53.6% | 0.00% | – |
| Q2 2015 | $14,000 | -88.7% | 817 | -92.4% | 0.00% | -100.0% |
| Q1 2015 | $124,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |